Groundbreaking genomic test could spare millions of breast cancer patients chemotherapyGroundbreaking genomic test could spare millions of breast cancer patients chemotherapy
Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy Millions of women with breast cancer could be spared chemotherapy with a groundbreaking genomic test, according to the results of a trial that could transform healthcare guidelines worldwide.Treatment for breast cancer, the world’s most prevalent form of the disease, involves surgery to remove tumours. Chemotherapy is then usually recommended when doctors believe there is a risk the disease will return. Continue reading…
13 Black Women Share How They Found the Strength to Survive—and Thrive—With Breast Cancer13 Black Women Share How They Found the Strength to Survive—and Thrive—With Breast Cancer
Here’s how they picked themselves back up after a devastating diagnosis.
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
Microdosing GLP-1s for cosmetic weight loss: Patients are asking me about it, TV and online ads are promoting it, friends are speculating about who’s doing it. But as someone who prescribes only legitimate GLP-1 therapies to people with obesity and weight-related metabolic diseases, I need to say this: Microdosing GLP-1s is not a thing. There Read More
Weight-loss drugs like GLP-1s are easy to buy online, raising overdose and safety concernsWeight-loss drugs like GLP-1s are easy to buy online, raising overdose and safety concerns
Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she said Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain Read More
Obesity may influence how breast cancer spreadsObesity may influence how breast cancer spreads
Obesity may change how early-stage breast cancer becomes invasive, according to a study by University of Oklahoma researchers published in The American Journal of Pathology.
GLP-1s and Chronic Pancreatitis; Hypoglycemia After Bowel Prep; Lower GI BleedingGLP-1s and Chronic Pancreatitis; Hypoglycemia After Bowel Prep; Lower GI Bleeding
(MedPage Today) — A real-world study of chronic pancreatitis found GLP-1 agonists to be associated with less pain medication use and lower risks for pancreatic interventions, including major surgery. (Gastro Hep Advances) The FDA expanded the… (MedPage Today) — A real-world study of chronic pancreatitis found GLP-1 agonists to be associated with less pain Read More
Health Roundup: GLP-1s, ‘Sweet Spot’ for Sleep, MoreHealth Roundup: GLP-1s, ‘Sweet Spot’ for Sleep, More
Dr. John Torres, NBC News medical contributor joins TODAY with a roundup of the biggest health stories people are talking about from GLP-1s, to sleep health. He breaks down new studies that show GLP-1s may have even more anti-inflammatory benefits other than just weight loss and explains how to find your “sweet spot” in sleep. Read More
CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlashCVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash
CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said. CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly Read More
Clinician Perspectives on Breast Cancer–Related Lymphedema Prospective ScreeningClinician Perspectives on Breast Cancer–Related Lymphedema Prospective Screening
This qualitative study explores clinicians’ perspectives on the barriers to and facilitators of prospective screening for lymphedema among breast cancer survivors.
Weight-loss program helps women battling breast cancerWeight-loss program helps women battling breast cancer
Women battling breast cancer can benefit from a phone-based weight loss program, according to a new study. The Breast Cancer Weight Loss (BWEL) program helped women drop excess pounds, improve their physical function and have a better quality of life overall, researchers are scheduled to report at the annual meeting of the American Society of Clinical Oncology (ASCO).